Table 4.

Relationship between expression of microtubule components, response, progression on therapy, and survival in 93 NSCLC patients treated with a vinorelbine-based regimen

nResponse rate (%)PProgression rate (%)PPFS (d)POS (d)P
Class II β-tubulin
Class III β-tubulin
Δ2 α-tubulin*
  • Abbreviations: PFS, progression-free survival; Progression, progression on therapy; OS, overall survival.

  • * Data missing for one patient.